158
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Urinary Metabolomic Profiling Reveals Biological Pathways and Predictive Signatures Associated with Childhood Asthma

, , , , , , ORCID Icon & ORCID Icon show all
Pages 713-724 | Published online: 18 Dec 2020

References

  • Asher I, Pearce N. Global burden of asthma among children. Int J Tuberc Lung Dis. 2014;18(11):1269–1278. doi:10.5588/ijtld.14.017025299857
  • Bruzzese JM, Kattan M. School-based interventions: where do we go from here? J Allergy Clin Immunol. 2019;143(2):550–551. doi:10.1016/j.jaci.2018.10.03130395889
  • Chen ZH, Wang PL, Shen HH. Asthma research in China: a five-year review. Respirology. 2013;18(Suppl 3):10–19. doi:10.1111/resp.1219624188199
  • Zhang J, Dai J, Yan L, et al. Air pollutants, climate, and the prevalence of pediatric asthma in urban areas of China. Biomed Res Int. 2016;2016:2935163. doi:10.1155/2016/293516327556031
  • Lee-Sarwar KA, Bacharier LB, Litonjua AA. Strategies to alter the natural history of childhood asthma. Curr Opin Allergy Clin Immunol. 2017;17(2):139–145. doi:10.1097/ACI.000000000000034028079559
  • Gong T, Lundholm C, Rejno G, Mood C, Langstrom N, Almqvist C. Parental socioeconomic status, childhood asthma and medication use–a population-based study. PLoS One. 2014;9(9):e106579. doi:10.1371/journal.pone.010657925188036
  • Gibeon D, Menzies-Gow A. Recent changes in the drug treatment of allergic asthma. Clin Med. 2013;13(5):477–481. doi:10.7861/clinmedicine.13-5-477
  • Tan HT, Sugita K, Akdis CA. Novel biologicals for the treatment of allergic diseases and asthma. Curr Allergy Asthma Rep. 2016;16(10):70. doi:10.1007/s11882-016-0650-527613653
  • Uwaezuoke SN, Ayuk AC, Eze JN. Severe bronchial asthma in children: a review of novel biomarkers used as predictors of the disease. J Asthma Allergy. 2018;11:11–18. doi:10.2147/JAA.S14957729398922
  • Manson SC, Brown RE, Cerulli A, Vidaurre CF. The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use. Respir Med. 2009;103(7):975–994. doi:10.1016/j.rmed.2009.01.00319372037
  • Jung J, Kim SH, Lee HS, et al. Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Clin Exp Allergy. 2013;43(4):425–433. doi:10.1111/cea.1208923517038
  • Ober C, Yao TC. The genetics of asthma and allergic disease: a 21st century perspective. Immunol Rev. 2011;242(1):10–30. doi:10.1111/j.1600-065X.2011.01029.x21682736
  • Moffatt MF, Gut IG, Demenais F, et al. A large-scale, consortium-based genomewide association study of asthma. N Engl J Med. 2010;363(13):1211–1221. doi:10.1056/NEJMoa090631220860503
  • Wishart DS. Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev. 2019;99(4):1819–1875. doi:10.1152/physrev.00035.201831434538
  • Khan A, Choi Y, Back JH, Lee S, Jee SH, Park YH. High-resolution metabolomics study revealing l-homocysteine sulfinic acid, cysteic acid, and carnitine as novel biomarkers for high acute myocardial infarction risk. Metabolism. 2019;104:154051. doi:10.1016/j.metabol.2019.15405131874143
  • Merino J, Leong A, Liu CT, et al. Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose. Diabetologia. 2018;61(6):1315–1324. doi:10.1007/s00125-018-4599-x29626220
  • Fitzpatrick AM, Park Y, Brown LA, Jones DP. Children with severe asthma have unique oxidative stress-associated metabolomic profiles. J Allergy Clin Immunol. 2014;133(1):258–61e1–8. doi:10.1016/j.jaci.2013.10.012
  • Pang Z, Wang G, Wang C, Zhang W, Liu J, Wang F. Serum metabolomics analysis of asthma in different inflammatory phenotypes: a cross-sectional study in northeast China. Biomed Res Int. 2018;2018:2860521. doi:10.1155/2018/286052130345296
  • Schmidt AJ, Borras E, Nguyen AP, Yeap D, Kenyon NJ, Davis CE. Portable exhaled breath condensate metabolomics for daily monitoring of adolescent asthma. J Breath Res. 2020;14(2):026001. doi:10.1088/1752-7163/ab35b531344695
  • Ho WE, Xu YJ, Cheng C, et al. Metabolomics reveals inflammatory-linked pulmonary metabolic alterations in a murine model of house dust mite-induced allergic asthma. J Proteome Res. 2014;13(8):3771–3782. doi:10.1021/pr500361524956233
  • McGeachie MJ, Dahlin A, Qiu W, et al. The metabolomics of asthma control: a promising link between genetics and disease. Immun Inflamm Dis. 2015;3(3):224–238. doi:10.1002/iid3.6126421150
  • Comhair SA, McDunn J, Bennett C, Fettig J, Erzurum SC, Kalhan SC. Metabolomic endotype of asthma. J Immunol. 2015;195(2):643–650. doi:10.4049/jimmunol.150073626048149
  • Tao JL, Chen YZ, Dai QG, et al. Urine metabolic profiles in paediatric asthma. Respirology. 2019;24(6):572–581. doi:10.1111/resp.1347930763984
  • Chawes BL, Giordano G, Pirillo P, et al. Neonatal urine metabolic profiling and development of childhood asthma. Metabolites. 2019;9(9):185. doi:10.3390/metabo9090185
  • Carraro S, Bozzetto S, Giordano G, et al. Wheezing preschool children with early-onset asthma reveal a specific metabolomic profile. Pediatr Allergy Immunol. 2018;29(4):375–382. doi:10.1111/pai.1287929468750
  • Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O’Byrne PM. The global initiative for asthma (GINA): 25 years later. Eur Respir J. 2019;54(2):1900598. doi:10.1183/13993003.00598-201931273040
  • Kind T, Wohlgemuth G, Lee DY, et al. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem. 2009;81(24):10038–10048. doi:10.1021/ac901952219928838
  • Dunn WB, Broadhurst D, Begley P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060–1083. doi:10.1038/nprot.2011.33521720319
  • Mahadevan S, Shah SL, Marrie TJ, Slupsky CM. Analysis of metabolomic data using support vector machines. Anal Chem. 2008;80(19):7562–7570. doi:10.1021/ac800954c18767870
  • Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi:10.1186/1471-2105-12-77
  • Xia J, Sinelnikov IV, Han B, Wishart DS. MetaboAnalyst 3.0–making metabolomics more meaningful. Nucleic Acids Res. 2015;43(W1):W251–7. doi:10.1093/nar/gkv38025897128
  • Collaborators GBDCRD. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5(9):691–706. doi:10.1016/S2213-2600(17)30293-X.28822787
  • Mordaunt D, Cox D, Fuller M. Metabolomics to improve the diagnostic efficiency of inborn errors of metabolism. Int J Mol Sci. 2020;21(4):1195. doi:10.3390/ijms21041195
  • Kelly RS, Chawes BL, Blighe K, et al. An integrative transcriptomic and metabolomic study of lung function in children with asthma. Chest. 2018;154(2):335–348. doi:10.1016/j.chest.2018.05.03829908154
  • Stewart CJ, Mansbach JM, Wong MC, et al. Associations of nasopharyngeal metabolome and microbiome with severity among infants with bronchiolitis. a multiomic analysis. Am J Respir Crit Care Med. 2017;196(7):882–891. doi:10.1164/rccm.201701-0071OC28530140
  • Stewart CJ, Mansbach JM, Ajami NJ, et al. Serum metabolome is associated with the nasopharyngeal microbiota and disease severity among infants with bronchiolitis. J Infect Dis. 2019;219(12):2005–2014. doi:10.1093/infdis/jiz02130629185
  • Nishiuma T, Nishimura Y, Okada T, et al. Inhalation of sphingosine kinase inhibitor attenuates airway inflammation in asthmatic mouse model. Am J Physiol Lung Cell Mol Physiol. 2008;294(6):L1085–93. doi:10.1152/ajplung.00445.200718359884
  • Price MM, Oskeritzian CA, Falanga YT, et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma. J Allergy Clin Immunol. 2013;131(2):501–11e1. doi:10.1016/j.jaci.2012.07.01422939756
  • Nakamura H, Hirabayashi T, Someya A, Shimizu M, Murayama T. Inhibition of arachidonic acid release and cytosolic phospholipase A2 alpha activity by D-erythro-sphingosine. Eur J Pharmacol. 2004;484(1):9–17. doi:10.1016/j.ejphar.2003.10.05314729377
  • Miyata J, Fukunaga K, Kawashima Y, Ohara O, Arita M. Cysteinyl leukotriene metabolism of human eosinophils in allergic disease. Allergol Int. 2020;69(1):28–34. doi:10.1016/j.alit.2019.06.00231248811
  • Ran S, Sun F, Song Y, Wang X, Hong Y, Han Y. The study of dried ginger and linggan wuwei jiangxin decoction treatment of cold asthma rats using gc-ms based metabolomics. Front Pharmacol. 2019;10:284. doi:10.3389/fphar.2019.0028431031619
  • Schranner D, Kastenmuller G, Schonfelder M, Romisch-Margl W, Wackerhage H. Metabolite concentration changes in humans after a bout of exercise: a systematic review of exercise metabolomics studies. Sports Med Open. 2020;6(1):11. doi:10.1186/s40798-020-0238-432040782
  • Chang C, Guo ZG, He B, Yao WZ. Metabolic alterations in the sera of Chinese patients with mild persistent asthma: a GC-MS-based metabolomics analysis. Acta Pharmacol Sin. 2015;36(11):1356–1366. doi:10.1038/aps.2015.10226526201
  • Saude EJ, Skappak CD, Regush S, et al. Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy. J Allergy Clin Immunol. 2011;127(3):757–64e1–6. doi:10.1016/j.jaci.2010.12.1077
  • Gall WE, Beebe K, Lawton KA, et al. alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population. PLoS One. 2010;5(5):e10883. doi:10.1371/journal.pone.001088320526369
  • Newman JC, Verdin E. beta-hydroxybutyrate: much more than a metabolite. Diabetes Res Clin Pract. 2014;106(2):173–181. doi:10.1016/j.diabres.2014.08.00925193333
  • Li X, Xu Z, Lu X, et al. Comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry for metabonomics: biomarker discovery for diabetes mellitus. Anal Chim Acta. 2009;633(2):257–262. doi:10.1016/j.aca.2008.11.05819166731
  • Wei T, Tian W, Liu F, Xie G. Protective effects of exogenous beta-hydroxybutyrate on paraquat toxicity in rat kidney. Biochem Biophys Res Commun. 2014;447(4):666–671. doi:10.1016/j.bbrc.2014.04.07424755084
  • Kajitani N, Iwata M, Miura A, et al. Prefrontal cortex infusion of beta-hydroxybutyrate, an endogenous NLRP3 inflammasome inhibitor, produces antidepressant-like effects in a rodent model of depression. Neuropsychopharmacol Rep. 2020;40:157–165. doi:10.1002/npr2.1209932125791
  • Krishnan M, Hwang JS, Kim M, et al. beta-hydroxybutyrate impedes the progression of alzheimer’s disease and atherosclerosis in apoe-deficient mice. Nutrients. 2020;12(2):471. doi:10.3390/nu12020471